Inventor
ANDERSON DAVID RANDOLPH
US15 patents
⚠️ This page may combine multiple inventors who share the name “ANDERSON DAVID RANDOLPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACLARIS THERAPEUTICS INC
10 patentsUS11739086B2Aug 29, 2023
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
ACLARIS THERAPEUTICS INC4 citations84
US10981906B2Apr 20, 2021
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
ACLARIS THERAPEUTICS INC9 citations84
US10800775B2Oct 13, 2020
Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same
ACLARIS THERAPEUTICS INC8 citations83
US12281111B2Apr 22, 2025
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
ACLARIS THERAPEUTICS INC1 citations73
US11820775B2Nov 21, 2023
Pyrrolopyrimidine ITK inhibitors
ACLARIS THERAPEUTICS INC2 citations70
US11021482B2Jun 1, 2021
Pyrrolopyrimidine ITK inhibitors
ACLARIS THERAPEUTICS INC2 citations70
US12297203B2May 13, 2025
Pyrrolopyrimidine ITK inhibitors
ACLARIS THERAPEUTICS INC0 citations59
US12403141B2Sep 2, 2025
Deuterated MK2 pathway inhibitors and methods of using the same
ACLARIS THERAPEUTICS INC0 citations52
US11420966B2Aug 23, 2022
Substituted pyrrolopyridines as JAK inhibitors
ACLARIS THERAPEUTICS INC0 citations46
US10316038B2Jun 11, 2019
Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer
ACLARIS THERAPEUTICS INC0 citations40
PFIZER
5 patentsUS9879022B2Jan 30, 2018
Bicyclic-fused heteroaryl or aryl compounds
PFIZER19 citations93
US11702424B2Jul 18, 2023
Bicyclic-fused heteroaryl or aryl compounds
PFIZER4 citations85
US10793579B2Oct 6, 2020
Bicyclic-fused heteroaryl or aryl compounds
PFIZER3 citations83
US10329302B2Jun 25, 2019
Bicyclic-fused heteroaryl or aryl compounds
PFIZER3 citations83
US12202836B2Jan 21, 2025
Bicyclic-fused heteroaryl or aryl compounds
PFIZER0 citations62